Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.

Chirurgia (Bucharest, Romania : 1990) - 1 Dec 2024

Popa Ana Maria, Cotan Horia Teodor, Iaciu Cristian I, Nitipir Cornelia

Abstract excerpt

OBJECTIVE: this retrospective study aimed to evaluate the impact of BRCA mutational status on the outcomes of patients with advanced ovarian cancer treated with either primary debulking surgery (PDS) or neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS). Material and Methods: a total of 79 patients with stage III-IV ovarian cancer treated at Elias Emergency University Hospital between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Kaplan-Meier Estimate

Share to Neoadjuvant Therapy

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 39737823
DOI: 10.21614/chirurgia.3055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.PMID 39737823Read ↗

Effects of neoadjuvant chemotherapy in ovarian cancer patients with different germline BRCA1/2 mutational status: A retrospective studySemantic proximity Read ↗

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancerSemantic proximity Read ↗

Germline BRCA, Chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancerSemantic proximity Read ↗

Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.Semantic proximity Read ↗

Association of BRCA1/2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta-analysis.Semantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).Semantic proximity Read ↗

Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer.Semantic proximity Read ↗

The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients.Semantic proximity Read ↗

Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018.Semantic proximity Read ↗

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.Semantic proximity Read ↗

Assessing Frequency and Clinical Outcomes of BRCA Mutated Ovarian Cancer in Saudi WomenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.